×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

More Options and Challenges: Bringing Drugs To Market Early

August 22, 2017

It can be expensive and time consuming to bring drugs to the market with increasingly more payers in the US and Europe demanding evidence on the benefits and impact on budget for newly approved drugs. But what options are there available to combat these challenges?

When developing an early market access strategy, companies must remember: 

• To engage with payers at the earliest opportunity 
• To gather data as soon as possible
• To keep referring back to the product strategy
• To consider alternative contracting options determining what type of agreement is right for each payer 
• To involve affiliates in core commercialization teams 

Previous Flipbook
Building Value With Real-World Data
Building Value With Real-World Data

Read this article to find out more about real world evidence!

Next Flipbook
New Science Demands Real World Data
New Science Demands Real World Data

Read this interview with Richard Bergström to find out more about obtaining positive reimbursement decision...